EA200700574A2 - Применение агомелатина в получении лекарственных средств, предназначенных для лечения генерализированного тревожного расстройства - Google Patents

Применение агомелатина в получении лекарственных средств, предназначенных для лечения генерализированного тревожного расстройства

Info

Publication number
EA200700574A2
EA200700574A2 EA200700574A EA200700574A EA200700574A2 EA 200700574 A2 EA200700574 A2 EA 200700574A2 EA 200700574 A EA200700574 A EA 200700574A EA 200700574 A EA200700574 A EA 200700574A EA 200700574 A2 EA200700574 A2 EA 200700574A2
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
disorder
agomelatin
reception
application
Prior art date
Application number
EA200700574A
Other languages
English (en)
Other versions
EA012608B1 (ru
EA200700574A3 (ru
Inventor
Брюно Делалло
Аньес Фабиано
Марк Миллан
Элизабет Мока
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37308935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200700574(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200700574A2 publication Critical patent/EA200700574A2/ru
Publication of EA200700574A3 publication Critical patent/EA200700574A3/ru
Publication of EA012608B1 publication Critical patent/EA012608B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к применению агомелатина или N-[2-(7-метокси-1-нафтил)этил]ацетамида, в получении лекарственных средств, предназначенных для лечения генерализированного тревожного расстройства.
EA200700574A 2006-04-07 2007-04-06 Применение агомелатина в получении лекарственных средств, предназначенных для лечения генерализованного тревожного расстройства EA012608B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603083A FR2899472B1 (fr) 2006-04-07 2006-04-07 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee

Publications (3)

Publication Number Publication Date
EA200700574A2 true EA200700574A2 (ru) 2007-10-26
EA200700574A3 EA200700574A3 (ru) 2007-12-28
EA012608B1 EA012608B1 (ru) 2009-10-30

Family

ID=37308935

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700574A EA012608B1 (ru) 2006-04-07 2007-04-06 Применение агомелатина в получении лекарственных средств, предназначенных для лечения генерализованного тревожного расстройства

Country Status (44)

Country Link
US (1) US7960438B2 (ru)
EP (1) EP1842535B1 (ru)
JP (1) JP4880031B2 (ru)
KR (1) KR20070100657A (ru)
CN (1) CN101049290B (ru)
AP (1) AP2488A (ru)
AR (1) AR060349A1 (ru)
AT (1) ATE477798T1 (ru)
AU (1) AU2007201527B2 (ru)
BR (1) BRPI0701601A (ru)
CA (1) CA2584060C (ru)
CO (1) CO5840252A1 (ru)
CR (1) CR9019A (ru)
CY (1) CY1111287T1 (ru)
DE (1) DE602007008494D1 (ru)
DK (1) DK1842535T3 (ru)
EA (1) EA012608B1 (ru)
ES (1) ES2351062T3 (ru)
FR (1) FR2899472B1 (ru)
GE (1) GEP20094743B (ru)
GT (1) GT200700032A (ru)
HK (1) HK1108367A1 (ru)
HR (1) HRP20100577T1 (ru)
IL (1) IL182407A (ru)
JO (1) JO3440B1 (ru)
MA (1) MA28987B1 (ru)
ME (1) ME01865B (ru)
MX (1) MX2007004100A (ru)
MY (1) MY143269A (ru)
NI (1) NI200700084A (ru)
NO (1) NO20071774L (ru)
NZ (1) NZ554347A (ru)
PE (1) PE20080174A1 (ru)
PL (1) PL1842535T3 (ru)
PT (1) PT1842535E (ru)
RS (1) RS51485B (ru)
SA (1) SA07280161B1 (ru)
SG (1) SG136881A1 (ru)
SI (1) SI1842535T1 (ru)
TN (1) TNSN07118A1 (ru)
TW (1) TWI374736B (ru)
UY (1) UY30262A1 (ru)
WO (1) WO2007116136A1 (ru)
ZA (1) ZA200702865B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
CN101585779B (zh) * 2009-03-10 2014-04-02 上海医药工业研究院 阿戈美拉汀的晶型vi及其制备方法和应用
FR2956031B1 (fr) * 2010-02-11 2012-03-02 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble obsessionnel compulsif (toc)
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
PH12012000132B1 (en) * 2011-06-09 2014-10-20 Servier Lab New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
HUE036989T2 (hu) 2013-06-06 2018-08-28 Zentiva Ks Agomelatin készítmény, amely agomelatint ko-kristály formájában tartalmaz
IT201900002913A1 (it) 2019-03-01 2020-09-01 Nicola Pescosolido Composto utile per il trattamento del glaucoma
CN110867197A (zh) * 2019-10-23 2020-03-06 吴杰 语音交互过程中实时打断语音机器人的方法及设备

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
SG45100A1 (en) * 1994-03-07 1998-01-16 Ibm Improvements in image processing
DE19532842C1 (de) * 1995-09-05 1996-12-19 Ibm Bildaufnahmesystem
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
EP1696959A2 (en) * 2003-12-24 2006-09-06 Sepracor, Inc. Melatonin combination therapy for improving sleep quality
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
JP2008531714A (ja) * 2005-03-04 2008-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 不安障害の治療用及び／又は予防用の医薬組成物
US7635721B2 (en) * 2005-08-03 2009-12-22 Les Laboratoires Servier Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TW200735878A (en) * 2005-11-18 2007-10-01 Astrazeneca Ab Pharmaceutical compositions

Also Published As

Publication number Publication date
EA012608B1 (ru) 2009-10-30
AU2007201527A1 (en) 2007-10-25
JO3440B1 (ar) 2019-10-20
FR2899472A1 (fr) 2007-10-12
PE20080174A1 (es) 2008-03-29
GT200700032A (es) 2007-10-31
GEP20094743B (en) 2009-07-27
AP2007003953A0 (en) 2007-04-30
MA28987B1 (fr) 2007-11-01
SG136881A1 (en) 2007-11-29
WO2007116136A1 (fr) 2007-10-18
EP1842535B1 (fr) 2010-08-18
US20070238792A1 (en) 2007-10-11
TNSN07118A1 (fr) 2008-06-02
NO20071774L (no) 2007-10-08
TW200808295A (en) 2008-02-16
IL182407A (en) 2016-02-29
DE602007008494D1 (de) 2010-09-30
HK1108367A1 (en) 2008-05-09
CY1111287T1 (el) 2015-08-05
ATE477798T1 (de) 2010-09-15
JP2009532446A (ja) 2009-09-10
JP4880031B2 (ja) 2012-02-22
RS51485B (en) 2011-04-30
TWI374736B (en) 2012-10-21
DK1842535T3 (da) 2010-11-15
EA200700574A3 (ru) 2007-12-28
CO5840252A1 (es) 2007-12-31
CA2584060A1 (fr) 2007-10-07
US7960438B2 (en) 2011-06-14
ZA200702865B (en) 2008-07-30
CR9019A (es) 2008-10-28
HRP20100577T1 (hr) 2010-11-30
BRPI0701601A (pt) 2007-12-11
AP2488A (en) 2012-10-03
ME01865B (me) 2011-04-30
EP1842535A1 (fr) 2007-10-10
CN101049290A (zh) 2007-10-10
AR060349A1 (es) 2008-06-11
PT1842535E (pt) 2010-09-28
SA07280161B1 (ar) 2010-10-23
UY30262A1 (es) 2007-05-31
KR20070100657A (ko) 2007-10-11
MX2007004100A (es) 2009-02-16
AU2007201527B2 (en) 2012-08-09
CA2584060C (fr) 2011-04-26
ES2351062T3 (es) 2011-01-31
FR2899472B1 (fr) 2008-09-12
NI200700084A (es) 2008-04-24
NZ554347A (en) 2008-08-29
PL1842535T3 (pl) 2011-01-31
CN101049290B (zh) 2012-10-31
MY143269A (en) 2011-04-15
SI1842535T1 (sl) 2010-10-29
IL182407A0 (en) 2008-01-20

Similar Documents

Publication Publication Date Title
EA200700574A2 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения генерализированного тревожного расстройства
EA200601449A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения нарушений сна у пациента с депрессией
DK2148670T3 (da) Titrering af tapentadol
EA200702318A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения синдрома смита-магениса
EA201201123A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения обсессивно-компульсивного расстройства (окр)
UY29470A1 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos bipolares
EA200702317A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения перивентрикулярной лейкомаляции
UA88322C2 (ru) Применение агомелатина как единственного активного агента в получении лекарственных средств, предназначенных для лечения генерализованного тревожного расстройства
CU20070070A7 (es) Composición farmacéutica de agomelatina
EA200601450A1 (ru) Новая комбинация агомелатина и тиморегулирующего средства и фармацевтические композиции, которые её содержат
CU20070232A7 (es) Utilización de la agomelatina para la obtención de medicamentos destinados al tratamiento de los trastornos bipolares